Joana Nicolau has received fees for presentations and consulting on behalf of Sanofi, Novo Nordisk, Lilly, Boehringer-Ingelheim, Fresenius, AstraZeneca, Fresenius, Dexcom, Amgen, and Senseonics
The PlexusDx Precision Peptide Genetic Test examines variants in peptide-pathway genes (GIPR, GLP1R, FTO, MC4R) that may help contextualize your metabolic response to GLP-1 therapy
While these average results are compelling, it's important to look beyond the averages
In conclusion, ALA supplementation may be considered a potential adjunctive treatment for patients with migraine (103, 107)
testosterone, growth hormone, IGF-1) can increase lean mass in selected patients, but require specialist oversight and carry safety concerns [73]